Cancer Research UK logo.
SearchDonate
  • Search

A trial of azacitidine and ruxolitinib for blood disorders called myeloproliferative neoplasms (PHAZAR)

Overview

Cancer types:

Blood cancers, Myelofibrosis, Polycythaemia, Thrombocythaemia

Status:

Closed

Phase:

Phase 1

Details

This trial is for people with advanced myeloproliferative neoplasms that include thrombocythaemia, polycythaemia vera or myelofibrosis.

Recruitment start: 5 January 2016

Recruitment end: 30 April 2019

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Mark Drummond

Supported by

Bloodwise

Celgene

Novartis

University of Birmingham

Last reviewed: 29 April 2019

CRUK internal database number: 12130

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.